https://www.selleckchem.com/pr....oducts/CP-690550.htm
es on CNS osimertinib pharmacokinetics are needed to test this hypothesis. Tinnitus is a serious late effect of childhood cancer treatment. The aim of this study was to determine the occurrence and risk factors for tinnitus in a national cohort of childhood cancer survivors (CCS). Data were collected within the national Dutch Childhood Oncology Group - Long-Term Effects after Childhood Cancer (DCOG-LATER) cohort by a self-reported health questionnaire among 5327 Dutch CCS treated between 1963 and 2002. Siblings ( = 1663) were invited
Like
Comment
Share
